STUDY DESIGN: A retrospective cohort study, including all SGA live infants (birth weight <10 th percentile for GA) with placental pathology reports, born at a single, tertiary medical center between 2001-2015 at >24 0/7 weeks. We categorized infants to one of three groups based on placental pathology: normal size placenta with no MVM (control group), small placentas (<10 th percentile) with no MVM (isolated small placenta group), and small placentas with MVM (MVM group). Pregnancy outcomes and Doppler findings were compared between the three groups. RESULTS: Overall, 920 SGA neonates were included in the study: 118 (12.8%) in the control group, 427 (46.4%) in the isolated small placenta group and 365 (39.8%) in the MVM group. The rates of hypertensive disorders and preterm birth were similar between the control and isolated small placenta groups, but were higher in the MVM group (Table 1) . Doppler data was available for a subgroup of 222 women ( Table 2 ). The rate of abnormal umbilical artery Doppler in the isolated small placenta group was similar to controls and significantly lower than in the MVM group. However, the rate of abnormal middle cerebral artery Doppler ('brain sparing effect') in the isolated small placenta group was higher than in the control group (Table 2) . CONCLUSION: In contrast to other MVM placental lesions, isolated small placenta in pregnancies with SGA is not associated with hypertensive complications, prematurity and low Apgar scores. However, isolated small placenta is associated with abnormal middle cerebral artery which is considered to be suggestive of FGR, especially in cases of late-onset FGR. These findings suggest that in pregnancies with SGA infants, a finding of an isolated small placenta should be interpreted as a marker of mild late-onset FGR rather than constitutional SGA.
137 Grand multiparity and great grand multiparity: obstetric risks in a contemporary cohort OBJECTIVE: Grand multiparity (GM) has been associated with adverse obstetric outcomes such as postpartum hemorrhage and preeclampsia. However, large populations of grand multiparas have not been studied in the United States. We sought to characterize obstetric risks in women with GM (5-9 births) and great-grand multiparity (GGM) (10 births) in a contemporary cohort. STUDY DESIGN: This was a retrospective cohort of all women who delivered at the Mount Sinai Hospital from 2011 to 2017 with parity of 5 or more prior births. Multiple gestations and duplicate pregnancies were excluded. Data on maternal demographics, medical history, and pregnancy complications were collected. The cohort was stratified into GM (parity 5-9) and GGM (parity 10). Sample characteristics and obstetric outcomes were compared using T-tests, Chi-square tests, Fisher's exact tests, and multivariable logistic regression. We also compared outcomes among patients with increasing parity using a Cochran-Armitage test for trend. Data were analyzed using SAS v9.4 with a p-value of <0.05 defined as significant. RESULTS: 922 women met inclusion criteria for review and analysis. 839 (91%) patients were GM and 83 (9%) patients were GGM. The median parity of the cohort was 6 prior births (IQR 5, 8; . GGM patients were significantly older (mean age 40.9 years vs. 35.8 years, p<0.0001), more likely to be white (98.8% vs. 88%, p¼0.03), and have private insurance (96.4% vs. 87.6%, p¼0.02). There were no statistically significant differences in BMI, chronic HTN, or GDM between the 2 groups. PPH was significantly higher in the GGM group vs the GM group (8.6% vs. 18.1%, p¼0.009) adjusting for age and obesity. The GGM group also had a higher use of prophylactic uterotonics (29.8% vs. 56.6%, p<0.0001). There was no significant difference in the composite or individual adverse outcomes (Table 1) or increases in complications with increasing parity (p¼0.72) (Figure 1) . CONCLUSION: This is the largest study to date in an urban US cohort examining risks of GM and GGM. In patients with GM, there does not appear to be an increased risk of delivery complications with increasing parity. GGM patients do not appear to have higher rates of complications relative to GM patients. These findings suggest that once they reach grand multiparity and continue to have children, they may represent a self-selected population of patients who are able to have further uncomplicated deliveries. outcomes OBJECTIVE: ACOG published guidelines in 2013 with specific delivery timing recommendations for various medical and fetal conditions in an effort to reduce maternal and neonatal morbidity. We sought to determine how the timing of the release of these guidelines influenced the rate of adverse neonatal outcomes. STUDY DESIGN: Using birth certificate records, we conducted a population based retrospective cohort study of all live births in Ohio from the years 2011-2012 (pre-guidelines, Epoch 1) and 2014-2015 (post-guidelines, Epoch 2). We compared frequency of composite adverse neonatal outcome defined as NICU admission, assisted ventilation (>6hrs), meconium, fetal intolerance of labor (FIOL), surfactant, seizure, low Apgar, or neonatal death between Epoch 1 and 2. We also analyzed individual adverse outcomes. We further stratified analyses by pregnancies complicated by the following medical conditions: chronic (CHTN) or gestational hypertension (GHTN), pre-gestational (PGD) or gestational diabetes (GDM), twin gestation, and fetal growth restriction (FGR). Other than twin gestation, analysis of each medical condition was limited to singleton births. RESULTS: 572,010 live births were included: 48.8% in Epoch 1 (2011 ( -2012 ( ) and 51.2% in Epoch 2 (2014 ( -2015 . Rates of composite adverse outcomes were significantly higher in Epoch 2 compared to Epoch 1 both overall and when stratified by medical condition. Epoch 2 additionally had significantly higher rates of assisted ventilation but significantly lower rates of infant death. Each medical condition was associated with increased rates of composite adverse outcomes in Epoch 2. The risks are increased despite slight increases in preterm births <37 weeks (12.1 v 13.6%, p<0.001) and early preterm births <34 weeks (4.1 v 4.8%, p<0.001) in Epoch 2. However, neonatal and infant death rates decreased significantly in cases of GHTN and twin gestation. Infant death rates also decreased in pregnancies with FGR and GDM.
CONCLUSION: Since the publication of society guidelines for medically indicated delivery timing, the rates of neonatal adverse outcomes have increased, but neonatal and infant death are on a favorable decline. Future studies should aim to elucidate the causal factors linking specific medical conditions to these neonatal outcomes, with efforts to align findings with future delivery timing recommendations.
